Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in Post-COVID-19 Syndrome (PCS)
NCT05986422Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2023
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in Post COVID-19 Syndrome (PCS), sponsored by Charité – Universitätsmedizin Berlin. Started Oct 2023; status: terminated.
02
Drugs
methylprednisolone
03
Conditions
Post COVID-19 Syndrome (PCS)
Beyond the preview
Go deeper on NCT05986422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05986422.